Actively Recruiting
Dismantling Exposure, Relaxation, and Rescripting Therapy
Led by University of Tulsa · Updated on 2024-07-03
50
Participants Needed
1
Research Sites
574 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this case series dismantling study is to extend previous findings regarding the efficacy of a brief treatment for chronic post-trauma nightmares by examining the dose effect and mechanism of change. Exposure, relaxation, and rescripting therapy (ERRT) is a promising psychological intervention developed to target trauma-related nightmares and sleep disturbances. ERRT has exhibited strong support in reducing the frequency and intensity of nightmares, as well as improving overall sleep quality in both civilian and veteran samples. In addition, significant decreases in PTSD and depression symptoms have been reported following treatment (Davis et al., 2011; Davis \& Wright, 2007; Long et al., 2011; Swanson, Favorite, Horin, \& Arnedt, 2009). ERRT is currently an evidence-level B suggested treatment (Cranston, Davis, Rhudy, \& Favorite, 2011). Despite this evidence, the mechanism of change for ERRT remains unclear. We propose to conduct a set of case series in order to examine the possible mechanisms: psycho-education, dose response for exposure, and no exposure components of the treatment. Each part of the treatment is theorized to contribute to the improved treatment outcome and it is hypothesized that participants will benefit no matter what group they are in. All participants will receive 5 to 6 treatment sessions, conducted once per week for about 90 minutes, of a modified version of ERRT.
CONDITIONS
Official Title
Dismantling Exposure, Relaxation, and Rescripting Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older at the time of the intake
- Experienced a traumatic event as defined by the Diagnostic and Statistical Manual (DSM-5)
- Have approximately one nightmare each week for the past month
- Able to read and speak English
You will not qualify if you...
- Age 17 years or younger
- Acute or apparent psychosis
- Unmedicated bipolar disorder
- Intellectual disability
- Active suicidality
- Recent parasuicidal behaviors
- Untreated substance use disorder in past 6 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Joanne L. Davis
Tulsa, Oklahoma, United States, 74104
Actively Recruiting
Research Team
J
Joanne L Davis, PhD
CONTACT
L
Lucia D Villarreal, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here